Biomarkers in inflammatory bowel disease: a practical guide
Inflammatory bowel disease (IBD), comprising ulcerative colitis (UC) and Crohn’s disease (CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing prevalence now approaching 1% in the Western world. Endoscopic assessment of IBD remains the gold standard for dia...
| Published in: | Therapeutic Advances in Gastroenterology |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-05-01
|
| Online Access: | https://doi.org/10.1177/17562848241251600 |